Thomas Appio named interim CEO of Bausch + Lomb, succeeding Brent Saunders. Appio remains CEO of parent Bausch Health. Company expects to raise full-year 2026 adjusted EBITDA guidance; details on Oct. 28.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
